Comparison of perfusion index in response to noxious stimulation under monitored anesthesia care: propofol / remifentanil vs propofol / dexmedetomidine
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0003501
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
American Society of Anesthesiologist (ASA) class I, II Adult
patients
Exclusion Criteria
Pediatric patients Patients with American Society of
Anesthesiologist (ASA) class III, IV Patients with a Body mass index (BMI)
greater than 30 Diabetes Peripheral obstructive blood vessel disease Patients
with heart disease (myocardial infarction, heart failure, arrhythmia) Patients
who is taking a / ß blocker pregnancy Anyone who is allergic to certain
anesthetics or drugs due to a history (propopol related allergy or history:
previous hypersensitivity reactions, hypersensitivity to soy or peanuts)
bradycardia (HR < 50 bpm) Chronic pain disorder Severe liver, kidney
disease
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method When remifentanil or dexmedetomidine are used for monitoring and <br>undergoing anesthesia, the difference in perfusion index between the two groups <br>is checked at postanesthesia care unit.
- Secondary Outcome Measures
Name Time Method Check the difference in perfusion index between the two groups <br>according to the surgical stimulation during the operation (local infiltraion at <br>surgical site, dilator insertion, and skin suture).